Stock Code: 300204 Stock Abbreviation: Shanshen Announcement No.: 2026-011
Shanshen (Beijing) Pharmaceutical Co., Ltd. Announcement on Polyethylene Glycol 3350 Powder Obtaining Drug Registration Certificate
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from any false representations, misleading statements, or material omissions.
Recently, Shanshen (Beijing) Pharmaceutical Co., Ltd. (hereinafter referred to as "Shanshen" or "the Company") received the Drug Registration Certificate for Polyethylene Glycol 3350 Powder, approved and issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), obtaining the drug production registration approval. The relevant situation is hereby announced as follows: